171 related articles for article (PubMed ID: 9820737)
21. Targeted polymers for gene delivery.
Hughes JA; Rao GA
Expert Opin Drug Deliv; 2005 Jan; 2(1):145-57. PubMed ID: 16296741
[TBL] [Abstract][Full Text] [Related]
22. Virus-based gene delivery systems.
Mah C; Byrne BJ; Flotte TR
Clin Pharmacokinet; 2002; 41(12):901-11. PubMed ID: 12222993
[TBL] [Abstract][Full Text] [Related]
23. To be targeted: is the magic bullet concept a viable option for synthetic nucleic acid therapeutics?
Ogris M; Wagner E
Hum Gene Ther; 2011 Jul; 22(7):799-807. PubMed ID: 21563983
[TBL] [Abstract][Full Text] [Related]
24. Intracellular trafficking of nonviral vectors.
Medina-Kauwe LK; Xie J; Hamm-Alvarez S
Gene Ther; 2005 Dec; 12(24):1734-51. PubMed ID: 16079885
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.
Li SD; Huang L
Gene Ther; 2006 Sep; 13(18):1313-9. PubMed ID: 16953249
[TBL] [Abstract][Full Text] [Related]
26. Saccharide modified pharmaceutical nanocarriers for targeted drug and gene delivery.
Yu W; Zhang N; Li C
Curr Pharm Des; 2009; 15(32):3826-36. PubMed ID: 19925431
[TBL] [Abstract][Full Text] [Related]
27. Polycation gene delivery systems: escape from endosomes to cytosol.
Cho YW; Kim JD; Park K
J Pharm Pharmacol; 2003 Jun; 55(6):721-34. PubMed ID: 12841931
[TBL] [Abstract][Full Text] [Related]
28. Targeting of polyplexes: toward synthetic virus vector systems.
Wagner E; Culmsee C; Boeckle S
Adv Genet; 2005; 53():333-54. PubMed ID: 16241000
[TBL] [Abstract][Full Text] [Related]
29. Viral vectors for gene therapy.
Robbins PD; Ghivizzani SC
Pharmacol Ther; 1998 Oct; 80(1):35-47. PubMed ID: 9804053
[TBL] [Abstract][Full Text] [Related]
30. Progress in cancer gene therapy.
Kouraklis G
Acta Oncol; 1999; 38(6):675-83. PubMed ID: 10522756
[TBL] [Abstract][Full Text] [Related]
31. Receptor-mediated gene transfer vectors: progress towards genetic pharmaceuticals.
Molas M; Gómez-Valadés AG; Vidal-Alabró A; Miguel-Turu M; Bermudez J; Bartrons R; Perales JC
Curr Gene Ther; 2003 Oct; 3(5):468-85. PubMed ID: 14529352
[TBL] [Abstract][Full Text] [Related]
32. Design, preparation and application of nucleic acid delivery carriers.
Yang J; Liu H; Zhang X
Biotechnol Adv; 2014; 32(4):804-17. PubMed ID: 24239630
[TBL] [Abstract][Full Text] [Related]
33. Virosome: a novel vector to enable multi-modal strategies for cancer therapy.
Kaneda Y
Adv Drug Deliv Rev; 2012 Jun; 64(8):730-8. PubMed ID: 21443915
[TBL] [Abstract][Full Text] [Related]
34. [Development and application of glycosylated particulate carriers for delivery of nucleic acid medicine].
Kawakami S
Yakugaku Zasshi; 2008 Dec; 128(12):1743-9. PubMed ID: 19043293
[TBL] [Abstract][Full Text] [Related]
35. Targetable gene delivery vectors.
Hallenbeck PL; Stevenson SC
Adv Exp Med Biol; 2000; 465():37-46. PubMed ID: 10810613
[TBL] [Abstract][Full Text] [Related]
36. Different approaches in the gene therapy of cancer.
Gough MJ; Vile RG
Forum (Genova); 1999; 9(3):225-36. PubMed ID: 10504170
[TBL] [Abstract][Full Text] [Related]
37. Artificial Virus as Trump-card to Resolve Exigencies in Targeted Gene Delivery.
Ajithkumar KC; Pramod K
Mini Rev Med Chem; 2018; 18(3):276-286. PubMed ID: 28552048
[TBL] [Abstract][Full Text] [Related]
38. Targeted synthetic gene delivery vectors.
Schaffer DV; Lauffenburger DA
Curr Opin Mol Ther; 2000 Apr; 2(2):155-61. PubMed ID: 11249636
[TBL] [Abstract][Full Text] [Related]
39. Noninfectious gene transfer and expression systems for cancer gene therapy.
Cooper MJ
Semin Oncol; 1996 Feb; 23(1):172-87. PubMed ID: 8607027
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy for cancer and metastatic disease.
Kesmodel SB; Spitz FR
Expert Rev Mol Med; 2003 Jun; 5(17):1-18. PubMed ID: 14585164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
